- Home
- GBDC vs ICUI Comparison
GBDC vs ICUI Comparison
Compare GBDC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBDC
- ICUI
- Stock Information
- Founded
- GBDC 2009
- ICUI 1984
- Country
- GBDC United States
- ICUI United States
- Employees
- GBDC N/A
- ICUI N/A
- Industry
- GBDC Finance: Consumer Services
- ICUI Medical/Dental Instruments
- Sector
- GBDC Finance
- ICUI Health Care
- Exchange
- GBDC Nasdaq
- ICUI Nasdaq
- Market Cap
- GBDC 4.0B
- ICUI 4.0B
- IPO Year
- GBDC 2010
- ICUI 1992
- Fundamental
- Price
- GBDC $14.76
- ICUI $162.32
- Analyst Decision
- GBDC Buy
- ICUI Buy
- Analyst Count
- GBDC 7
- ICUI 4
- Target Price
- GBDC $16.36
- ICUI $138.33
- AVG Volume (30 Days)
- GBDC 1.5M
- ICUI 257.7K
- Earning Date
- GBDC 08-05-2024
- ICUI 08-07-2024
- Dividend Yield
- GBDC 7.86%
- ICUI N/A
- EPS Growth
- GBDC 63.15
- ICUI N/A
- EPS
- GBDC 1.58
- ICUI N/A
- Revenue
- GBDC $664,811,000.00
- ICUI $2,304,277,000.00
- Revenue This Year
- GBDC $24.23
- ICUI $3.80
- Revenue Next Year
- GBDC $23.67
- ICUI $4.01
- P/E Ratio
- GBDC $9.35
- ICUI N/A
- Revenue Growth
- GBDC 19.10
- ICUI 0.46
- 52 Week Low
- GBDC $13.95
- ICUI $78.28
- 52 Week High
- GBDC $17.72
- ICUI $166.46
- Technical
- Relative Strength Index (RSI)
- GBDC 41.97
- ICUI 66.44
- Support Level
- GBDC $14.73
- ICUI $159.10
- Resistance Level
- GBDC $15.04
- ICUI $166.46
- Average True Range (ATR)
- GBDC 0.18
- ICUI 3.76
- MACD
- GBDC 0.03
- ICUI -0.98
- Stochastic Oscillator
- GBDC 15.79
- ICUI 66.72
About GBDC Golub Capital BDC Inc.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if they were rated.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.